Neutra Corp. cash flow statement NTRR

Annual Quarterly

In fiscal 2023, which ended Jan 31, 2023, Neutra Corp. used $153,243 of cash from operations, up 62.2% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2024 Oct 31, 2023	FY 2023 Jan 31, 2023	FY 2022 Jan 31, 2022	FY 2021 Jan 31, 2021	FY 2020 Jan 31, 2020	FY 2019 Jan 31, 2019	FY 2018 Jan 31, 2018	FY 2015 Jan 31, 2015	FY 2014 Jan 31, 2014	FY 2012 Jan 31, 2013	FY 2011 Jan 31, 2012
Operating
Depreciation and amortization	0 -22.0%	0 +1.4%	0 +153.7%	0	—	—	—	—	—	—	—
Operating cash flow	-0 +95.3%	-0 +62.2%	-0 +1.6%	-0 -127.1%	-0 +56.4%	-0 -282.8%	-0	-1 +31.7%	-1	-0 -258.6%	-0
Investing
Capital expenditures	—	—	0 -79.5%	0	—	—	—	—	—	—	—
Investing cash flow	—	—	-0 +79.5%	-0	—	—	—	-0	—	—	—
Financing
Short-term debt issued	—	—	—	—	—	—	—	1 -26.6%	1	0 +372.4%	0
Financing cash flow	0 -94.4%	0 -63.6%	0 -6.9%	0 +26.8%	0 -14.0%	0 +282.8%	0	1 -26.6%	1	0 +152.8%	0
Change in cash
Free cash flow	—	—	-0 +26.8%	-1	—	—	—	—	—	—	—
Ratios
Free cash flow margin	—	—	-484.54%	-6,285.41%	—	—	—	—	—	—	—
Capital expenditures to revenue	—	—	43.72%	2,028.39%	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: NTRR (OTC)
Fiscal year ends: January 31
Incorporated in: WY
Headquarters: Houston, TX
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1512886

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.